Article

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice

2023-10-20

Abstract excerpt

Abstract Background and Purpose Pneumoconiosis, especially silicosis has emerged as a prominent occupational disease with remarkable global implications with no definitive cure available. While pirfenidone and nintedanib have been approved in treating idiopathic pulmonary fibrosis, their potential efficacy as anti-fibrotic agents in advanced silicosis warrants further investigation. Thus, we aimed to assess the in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2e3d3d84-861e-55db-91bc-c70082ef6202
DOI: 10.22541/au.169779616.60916387/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in miceDOI 10.22541/au.169779616.60916387/v1Read

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity Read

Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin modelSemantic proximity Read

A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy.Semantic proximity Read

Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.Semantic proximity Read

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary FibrosisSemantic proximity Read

An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.Semantic proximity Read

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF-β signaling and MicroRNAsSemantic proximity Read

Recent advances in understanding idiopathic pulmonary fibrosisSemantic proximity Read

Cellular And Molecular Genetic Mechanisms Of Lung Fibrosis Development And The Role Of Vitamin D: ReviewSemantic proximity Read

Inhibition of fibrosis with multi-agent therapy in pulmonary fibrosis: Results of a drug library screeningSemantic proximity Read

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.Semantic proximity Read

Novel Lipidomes Profile and Clinical Phenotype Identified in Pneumoconiosis PatientsSemantic proximity Read